Edition:
United States

Profile: Sensus Healthcare Inc (SRTS.PH)

SRTS.PH on Philadelphia Stock Exchange

5.50USD
13 May 2019
Change (% chg)

-- (--)
Prev Close
$5.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,022
52-wk High
$8.51
52-wk Low
$5.30

Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, incorporated on May 7, 2010, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The Company's product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.

The SRT-100 provides healthcare providers and patients with a painless and substantially non-scarring treatment option for non-melanoma skin cancer and other skin conditions. The SRT-100 can be used to remove basal cell carcinoma on the face, arms, legs, back and trunk. The SRT-100 can be used to remove squamous cell carcinoma anywhere on the body. Along with keloid removal, the SRT-100 can also be used as a preventative treatment to ensure keloids do not have the chance to grow in patients predisposed to developing them following general surgery. The SRT-100 offers a range of treatment applicators, which include Skin Cancer Applicator Set, Keloids Applicator Set, Safety Block, and Automatic Applicator Sensing and Display. The Company also offers the SRT-100 Vision, which treats non-melanoma skin cancer and unsightly keloid scarring. The SRT-100 Vision's features include High-Frequency Ultrasound Image Guidance System; Laser Positioning System; Lesioncam; Touch-Screen Control Console and Control Module; Audio/Visual Monitor; Automatic Al and Cu Filter Magazine; Electronic Medical Records (EMR), HL7 and PDF Record and Report Export; Dosimetry-Record and Verify, and Radcheck QC. The Company focuses on primary markets, including private dermatology practices and radiation oncologists in both private and hospital settings.

Company Address

Sensus Healthcare Inc

851 Broken Sound Pkwy NW Ste 215
BOCA RATON   FL   33487-3635
P: +1561.9225808
F: +1561.9482071

Company Web Links